litlas
Log inCreate account

Dean J. Kereiakes

Active 1984–2025

Also published as
DEAN J. KEREIAKES · Dean J Kereiakes
212
Papers
55,414
Citations
115
h-index
209
i10-index

Citations

Citations per year for Dean J. Kereiakes1947: 1 citations1985: 1 citations1986: 1 citations1987: 4 citations1988: 23 citations1989: 39 citations1990: 67 citations1991: 61 citations1992: 66 citations1993: 74 citations1994: 67 citations1995: 114 citations1996: 95 citations1997: 93 citations1998: 122 citations1999: 85 citations2000: 110 citations2001: 146 citations2002: 182 citations2003: 237 citations2004: 330 citations2005: 407 citations2006: 396 citations2007: 378 citations2008: 307 citations2009: 255 citations2010: 268 citations2011: 255 citations2012: 263 citations2013: 254 citations2014: 214 citations2015: 285 citations2016: 347 citations2017: 366 citations2018: 260 citations2019: 954 citations2020: 877 citations2021: 724 citations2022: 529 citations2023: 451 citations2024: 739 citations2025: 283 citations2026: 9 citations1948–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,989 citing papers, 26.7% of this breakdownUnited Kingdom: 1,059 citing papers, 7.1% of this breakdownGermany: 1,002 citing papers, 6.7% of this breakdownItaly: 915 citing papers, 6.1% of this breakdownCanada: 788 citing papers, 5.3% of this breakdownNetherlands: 741 citing papers, 5% of this breakdownFrance: 707 citing papers, 4.7% of this breakdownChina: 515 citing papers, 3.5% of this breakdownSwitzerland: 461 citing papers, 3.1% of this breakdownJapan: 428 citing papers, 2.9% of this breakdownSpain: 395 citing papers, 2.6% of this breakdownAustralia: 330 citing papers, 2.2% of this breakdown
0%26.7%Other 24.1%

Institutions

Fields

  • Medicine90.4%
  • Biochemistry, Genetics and Molecular Biology4.3%
  • Engineering1.1%
  • Materials Science1%
  • Immunology and Microbiology0.6%
  • Economics, Econometrics and Finance0.4%
  • Other2.2%

Topics

  • Coronary Interventions and Diagnostics10.7%
  • Acute Myocardial Infarction Research8.7%
  • Cardiac Valve Diseases and Treatments7.4%
  • Antiplatelet Therapy and Cardiovascular Diseases6.4%
  • Cardiac Imaging and Diagnostics6.2%
  • Aortic Disease and Treatment Approaches3.4%
  • Other57.2%

Coauthors

All papers

Open in search
  1. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients

    Authors: Martin B. Leon, Craig R. Smith, Michael J. Mack, Raj Makkar, Lars G. Svensson, Susheel Kodali, Vinod H. Thourani, E. Murat Tuzcu, D. Craig Miller, Howard C. Herrmann, Darshan Doshi, David J. Cohen, Augusto D. Pichard, Samir Kapadia, Todd Dewey, Vasilis Babaliaros, Wilson Y. Szeto, Mathew Williams, Dean J. Kereiakes, Alan Zajarías, Kevin L. Greason, Brian Whisenant, Robert W. Hodson, Jeffrey W. Moses, Alfredo Trento, David L. Brown, William F. Fearon, Philippe Pîbarot, Rebecca T. Hahn, Wael A. Jaber, William N. Anderson, Maria Alu, John G. Webb - New England Journal of Medicine 2016 cited by 5,034

  2. Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement

    Authors: Raj Makkar, Vinod H. Thourani, Michael J. Mack, Susheel Kodali, Samir Kapadia, John G. Webb, Sung‐Han Yoon, Alfredo Trento, Lars G. Svensson, Howard C. Herrmann, Wilson Y. Szeto, D. Craig Miller, Lowell F. Satler, David J. Cohen, Todd Dewey, Vasilis Babaliaros, Mathew Williams, Dean J. Kereiakes, Alan Zajarías, Kevin L. Greason, Brian Whisenant, Robert W. Hodson, David L. Brown, William F. Fearon, Mark J. Russo, Philippe Pîbarot, Rebecca T. Hahn, Wael A. Jaber, Erin Rogers, Ke Xu, Jaime Wheeler, Maria Alu, Craig R. Smith, Martin B. Leon - New England Journal of Medicine 2020 cited by 811

  3. Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease

    Authors: Jonathan Hill, Dean J. Kereiakes, Richard Shlofmitz, Andrew Klein, Robert F. Riley, Matthew J. Price, Howard C. Herrmann, William Bachinsky, Ron Waksman, Gregg W. Stone - Journal of the American College of Cardiology 2020 cited by 389

  4. Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

    Authors: Laura Mauri, Dean J. Kereiakes, Robert W. Yeh, Priscilla Driscoll-Shempp, Donald E. Cutlip, Philippe Gabríel Steg, Sharon‐Lise T. Normand, Eugene Braunwald, Stephen D. Wiviott, David J. Cohen, David R. Holmes, Mitchell W. Krucoff, James Hermiller, Harold L. Dauerman, Daniel I. Simon, David E. Kandzari, Kirk N. Garratt, David P. Lee, Thomas Pow, Peter Ver Lee, Michael J. Rinaldi, Joseph M. Massaro - New England Journal of Medicine 2014 cited by 1,898

  5. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention

    Authors: Robert W. Yeh, Eric A. Secemsky, Dean J. Kereiakes, Sharon‐Lise T. Normand, Anthony Gershlick, David J. Cohen, John A. Spertus, Philippe Gabríel Steg, Donald E. Cutlip, Michael J. Rinaldi, Edoardo Camenzind, William Wijns, Patricia Apruzzese, Yang Song, Joseph M. Massaro, Laura Mauri, for the DAPT Study Investigators - JAMA 2016 cited by 911

  6. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis

    Authors: Vinod H. Thourani, Susheel Kodali, Raj Makkar, Howard C. Herrmann, Mathew Williams, Vasilis Babaliaros, Richard W. Smalling, Scott Lim, S. Chris Malaisrie, Samir Kapadia, Wilson Y. Szeto, Kevin L. Greason, Dean J. Kereiakes, Gorav Ailawadi, Brian Whisenant, Chandan Devireddy, Jonathon Leipsic, Rebecca T. Hahn, Philippe Pîbarot, Neil J. Weissman, Wael A. Jaber, David J. Cohen, Rakesh M. Suri, E. Murat Tuzcu, Lars G. Svensson, John G. Webb, Jeffrey W. Moses, Michael J. Mack, D. Craig Miller, Craig R. Smith, Maria Alu, Rupa Parvataneni, Ralph B. D’Agostino, Martin B. Leon - The Lancet 2016 cited by 1,026

  7. Intravascular Lithotripsy for Treatment of Calcified Coronary Lesions

    Authors: Dean J. Kereiakes, Carlo Di Mario, Robert F. Riley, Jean Fajadet, Richard Shlofmitz, Shigeru Saito, Ziad A. Ali, Andrew Klein, Matthew J. Price, Jonathan Hill, Gregg W. Stone - JACC: Cardiovascular Interventions 2021 cited by 162

  8. Principles of Intravascular Lithotripsy for Calcific Plaque Modification

    Authors: Dean J. Kereiakes, Renu Virmani, Jason Y Hokama, Uday Illindala, Carlos Mena‐Hurtado, Andrew Holden, Jonathan Hill, Sean P. Lyden, Ziad A. Ali - JACC: Cardiovascular Interventions 2021 cited by 197

  9. Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study

    Authors: Torsten Vahl, Vinod H. Thourani, Raj Makkar, Nadira Hamid, Omar Khalique, David Daniels, James M. McCabe, Lowell F. Satler, Mark J. Russo, Wen Cheng, Isaac George, Gabriel S. Aldea, Brett C. Sheridan, Dean J. Kereiakes, Harsh Golwala, Firas Zahr, Stanley Chetcuti, Pradeep Yadav, Susheel Kodali, Hendrik Treede, Stephan Baldus, Nicholas Amoroso, Lauren S. Ranard, Duane S. Pinto, Martin B. Leon - The Lancet 2024 cited by 140

  10. Safety and Effectiveness of Coronary Intravascular Lithotripsy for Treatment of Calcified Nodules

    Authors: Ziad A. Ali, Dean J. Kereiakes, Jonathan Hill, Shigeru Saito, Carlo Di Mario, Benjamin Honton, Nieves Gonzalo, Robert F. Riley, Akiko Maehara, Mitsuaki Matsumura, Gregg W. Stone, Richard Shlofmitz - JACC: Cardiovascular Interventions 2023 cited by 48

  11. Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

    Authors: Jeffrey W. Moses, Martin B. Leon, Jeffrey J. Popma, Peter J. Fitzgerald, David R. Holmes, Charles O’Shaughnessy, Ronald Caputo, Dean J. Kereiakes, David O. Williams, Paul S. Teirstein, Judith Jaeger, Richard E. Kuntz - New England Journal of Medicine 2003 cited by 4,224

  12. Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease

    Authors: Paul A. Gurbel, Kevin P. Bliden, Kathleen Butler, Udaya S. Tantry, Tania Gesheff, Cheryl Wei, Renli Teng, Mark J. Antonino, Shankar B. Patil, Arun Karunakaran, Dean J. Kereiakes, Cordel Parris, Drew A. Purdy, Vance Wilson, Gary S. Ledley, Robert F. Storey - Circulation 2009 cited by 1,147

  13. Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study

    Authors: Dean J. Kereiakes, Jennifer G. Robinson, Christopher P. Cannon, Christelle Lorenzato, Robert Pordy, Umesh Chaudhari, Helen M. Colhoun - American Heart Journal 2015 cited by 347

  14. Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, SAR236553/REGN727, in Patients With Primary Hypercholesterolemia Receiving Ongoing Stable Atorvastatin Therapy

    Authors: James M. McKenney, Michael J. Koren, Dean J. Kereiakes, Corinne Hanotin, Anne-Catherine Ferrand, Evan A. Stein - Journal of the American College of Cardiology 2012 cited by 507

  15. PreSERVE-AMI

    Authors: Arshed A. Quyyumi, Alejandro Arias Vásquez, Dean J. Kereiakes, Marc Klapholz, Gary L. Schaer, Ahmed Abdel‐Latif, Stephen Frohwein, Timothy D. Henry, Richard A. Schatz, Nabil Dib, Catalin Toma, Charles J. Davidson, Gregory W. Barsness, David M. Shavelle, Martin Cohen, Joseph Poole, Thomas J. Moss, Pamela Hyde, Anna Maria Kanakaraj, Vitaly Druker, Amy W. Chung, Candice Junge, Robert A. Preti, Robin L. Smith, David J. Mazzo, Andrew L. Pecora, Douglas W. Losordo - Circulation Research 2016 cited by 154

  16. 5-Year Outcomes After Bioresorbable Coronary Scaffolds Implanted With Improved Technique

    Authors: Gregg W. Stone, Dean J. Kereiakes, Tommaso Gori, D. Christopher Metzger, Bernardo Stein, Matthew Erickson, Jan Torzewski, Ameer Kabour, Guy Piegari, Jeffrey J. Cavendish, Barry Bertolet, Kelly A. Stockelman, Nick E.J. West, Ori Ben‐Yehuda, James W. Choi, Steven O. Marx, John A. Spertus, Stephen G. Ellis - Journal of the American College of Cardiology 2023 cited by 60

  17. Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis

    Authors: Eliano Pio Navarese, Alexandra J. Lansky, Dean J. Kereiakes, Jacek Kubica, Paul A. Gurbel, Diana A. Gorog, Marco Valgimigli, Nick Curzen, David E. Kandzari, Marc P. Bonaca, Marc A. Brouwer, Julia M. Umińska, Miłosz Jaguszewski, Paolo Raggi, Ron Waksman, Martin B. Leon, William Wijns, Felicita Andreotti - European Heart Journal 2021 cited by 151

  18. Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial

    Authors: Raj Makkar, Dean J. Kereiakes, Frank Aguirre, Glen J. Kowalchuk, Tarun Chakravarty, Konstantinos Malliaras, Gary S. Francis, Thomas J. Povsic, Richard A. Schatz, Jay H. Traverse, Janice M. Pogoda, Rachel Smith, Linda Marbán, Deborah D. Ascheim, Mohammad R. Ostovaneh, João A.C. Lima, Anthony N. DeMaria, Eduardo Marbán, Timothy D. Henry - European Heart Journal 2020 cited by 126

  19. Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption

    Authors: Dean J. Kereiakes, Stephen G. Ellis, D. Christopher Metzger, Ronald Caputo, David G. Rizik, Paul S. Teirstein, Marc R. Litt, Annapoorna Kini, Ameer Kabour, Steven O. Marx, Jeffrey J. Popma, Siok Hwee Tan, Divine Ediebah, Charles A. Simonton, Gregg W. Stone, For the ABSORB III Investigators - Circulation 2019 cited by 92

  20. Impact of Calcium Eccentricity on the Safety and Effectiveness of Coronary Intravascular Lithotripsy: Pooled Analysis From the Disrupt CAD Studies

    Authors: Ziad A. Ali, Dean J. Kereiakes, Jonathan Hill, Shigeru Saito, Carlo Di Mario, Benjamin Honton, Nieves Gonzalo, Robert F. Riley, Akiko Maehara, Mitsuaki Matsumura, Doosup Shin, Gregg W. Stone, Richard Shlofmitz - Circulation Cardiovascular Interventions 2023 cited by 44

  21. Machine learning method for predicting pacemaker implantation following transcatheter aortic valve replacement

    Authors: Vien T. Truong, Daniel Beyerbach, Wojciech Mazur, Matthew Wigle, Emma A. Bateman, Akhil Pallerla, Tam N.M. Ngo, Satya Shreenivas, Justin T. Tretter, Cassady Palmer, Dean J. Kereiakes, Eugene S. Chung - Pacing and Clinical Electrophysiology 2021 cited by 32

  22. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis

    Authors: Susheel Kodali, Vinod H. Thourani, Jonathon White, S. Chris Malaisrie, Scott Lim, Kevin L. Greason, Mathew Williams, Mayra Guerrero, Andrew C. Eisenhauer, Samir Kapadia, Dean J. Kereiakes, Howard C. Herrmann, Vasilis Babaliaros, Wilson Y. Szeto, Rebecca T. Hahn, Philippe Pîbarot, Neil J. Weissman, Jonathon Leipsic, Philipp Blanke, Brian Whisenant, Rakesh M. Suri, Raj Makkar, Girma Ayele, Lars G. Svensson, John G. Webb, Michael J. Mack, Craig R. Smith, Martin B. Leon - European Heart Journal 2016 cited by 351

  23. 2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy

    Authors: Ziad A. Ali, Patrick W. Serruys, Takeshi Kimura, Runlin Gao, Stephen G. Ellis, Dean J. Kereiakes, Yoshinobu Onuma, Charles A. Simonton, Zhen Zhang, Gregg W. Stone - The Lancet 2017 cited by 207

  24. 3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds

    Authors: Dean J. Kereiakes, Stephen G. Ellis, Christopher Metzger, Ronald Caputo, David G. Rizik, Paul S. Teirstein, Marc R. Litt, Annapoorna Kini, Ameer Kabour, Steven O. Marx, Jeffrey J. Popma, Robert McGreevy, Zhen Zhang, Charles A. Simonton, Gregg W. Stone - Journal of the American College of Cardiology 2017 cited by 264